Cholecystectomy and Diagnosis-Related Groups (DRGs): 

patient classification and hospital reimbursement in 11 

European countries by Paat-Ahi, Gerli et al.
Cholecystectomy and Diagnosis-Related Groups (DRGs): 
patient classification and hospital reimbursement in 11 
European countries
Gerli Paat-Ahi1,2,*, Ain Aaviksoo1,3, Maria Świderek4,5 - on behalf of the EuroDRG group
Abstract
Background: As part of the EuroDRG project, researchers from eleven countries (i.e. Austria, England, Estonia, 
Finland, France, Germany, Ireland, Netherlands, Poland, Sweden, and Spain) compared how their Diagnosis-Related 
Groups (DRG) systems deal with cholecystectomy patients. The study aims to assist surgeons and national authorities 
to optimize their DRG systems. 
Methods: National or regional databases were used to identify hospital cases with a procedure of cholecystectomy. DRG 
classification algorithms and indicators of resource consumption were compared for those DRGs that individually 
contained at least 1% of cases. Six standardised case vignettes were defined, and quasi prices according to national 
DRG-based hospital payment systems were ascertained and compared to an index case. 
Results: European DRG systems vary widely: they classify cholecystectomy patients according to different sets of 
variables into diverging numbers of DRGs (between two DRGs in Austria and Poland to nine DRGs in England). The 
most complex DRG is valued at four times more resource intensive than the index case in Ireland but only 1.3 times 
more resource intensive than the index case in Austria. 
Conclusion: Large variations in the classification of cholecystectomy patients raise concerns whether all systems rely 
on the most appropriate classification variables. Surgeons, hospital managers and national DRG authorities should 
consider how other countries’ DRG systems classify cholecystectomy patients in order to optimize their DRG systems 
and to ensure fair and appropriate reimbursement.
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Implications for policy makers
• The result of this study can help policy-makers to consider alternative and possibly better ways to classify their patients into Diagnosis-
Related Groups (DRG). 
• DRG systems are meant to provide precise measures of the kind of services hospitals deliver. 
• The international comparisons can provide a very useful new perspective especially when governments, Ministries of Health or payers 
are thinking about how to improve an existing DRG system. 
• These researches can also allow countries, which are introducing DRG system, to avoid making gross errors or mistakes in composing 
their own DRG system.
Implications for public
Surgeons and national Diagnosis-Related Group (DRG) authorities should consider how other countries’ DRG systems classify 
cholecystectomy patients in order to optimize their DRG systems and to ensure fair and appropriate reimbursement.
Key Messages 
Introduction
Gallbladder surgery is one of the most frequent major 
surgeries in general surgery departments (1) and a 
cholecystectomy procedure is considered a benchmark 
procedure for a surgeon and surgical department (due to high 
prevalence, relevant impact on the population’s health, high 
clinical variability, and substantial use of resources) (2,3).
Diagnosis-Related Groups (DRGs) are Patient Classification 
Systems (PCSs), which are commonly used to classify, 
benchmark and ultimately pay for hospital treatment (4).
In current DRG-type hospital payment systems, DRGs 
define the payment categories, i.e. hospital products (4). As 
such, they are designed to increase the transparency about 
the services and provide incentives for the efficient use of 
resources within hospitals (4). Another type of standardized 
agreement in healthcare are clinical guidelines, which 
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are also used for guiding decisions and criteria regarding 
diagnosis, management and treatment, and are increasingly 
used as benchmarks for high quality care. It is important that 
management tools, which provide administrative incentives 
for clinical decision-making, are coherent. All the above also 
applies to Episodes of Care (EoC)1, such as cholecystectomy.
Classifications in healthcare are needed to transform 
information about human health and medical interventions 
to facilitate aggregation, analysis, decision-making and 
learning among people, and increasingly between software 
agents (5).
A well-designed classification system that is serving as 
the basis for a fair hospital payment or as the basis of 
performance comparisons should assure homogenous 
groups of patients based on most important determinants of 
resource consumption as classification variables and do so in 
a systematic manner (6). Otherwise, DRGs do not adequately 
control for differences of patients within different groups and 
reimbursement or benchmarking for some patient groups will 
not be adequate (4). It is also possible that if the PCS that is 
used for payment and benchmarking purposes is performing 
inadequately, it creates a potential conflict of incentives for 
clinical professionals and managers (7,8).
DRG systems usually group treatment cases on the basis of 
classification variables such as diagnoses, procedures and 
demographic characteristics. However, DRG systems in 
different countries and sometimes even within countries vary 
a lot, and they are in a constant state of evolving (4).
Very often professional specialist experts or consultants 
formally participate in the process of selection, definition, 
and update of classification criteria for respective DRGs (9). 
Thus, it is of utmost importance both for specialist groups 
such as surgeons as well as hospital managers to be aware 
of how their respective patients are classified by their DRG 
system in order to assess whether the classification variables 
adequately reflect differences in the complexity of treating 
different groups of patients using different techniques.
Comparison of different countries’ DRG systems classification 
principles can help surgeons to identify potential scope for 
improvement of their system or find cross-country agreement 
in classification principles in the same manner and direction 
as clinical guidelines. Also, analysing the different approaches 
to assigning a value and reimbursement tag for similar 
patients in other DRG systems may inform and support 
discussions about the adequacy of the existing practice. To 
the best of our knowledge, detailed comparative analyses of 
classification algorithms for cholecystectomy are very scarce, 
suffer from a very limited scope, and have not assessed the 
classification of patients using routine inpatient data (10).
Overall, studies across Europe suggest DRG-based payment 
systems have been associated with reduction in unit costs but 
also with an increase in total cost, due in part, to increased 
activity (4). Whether this has improved system efficiency 
depends on a number of factors, including: the impact on 
quality; the ‘value’ of the additional activity in terms of health 
gain; and whether there was cost-shifting (for example, with 
greater costs being borne in community and primary care 
from earlier discharge for patients) and gaming of the system 
1. The EoCs are uniformly defined across countries through diagnosis and/or procedure 
codes and can be understood as ‘meta-DRGs’ which encompass varying numbers of actual 
DRGs within countries.
(through up-coding and patient selection). Very few studies 
have examined the impact of payments based on DRGs on 
system-wide efficiency (11).
For hospital care, case-mix adjusted bundled payments are 
well established across Europe and are being expanded to 
cover more types of inpatient care. While having had an 
impact in Europe, with respect to increasing activity and 
reducing Length of Stay (LOS), DRG-type payments  may 
not alone help to improve the quality of care (particularly the 
coordination of care for patients beyond hospital settings), or 
control overall costs of hospital care (11).
This study therefore performs a comprehensive assessment 
of DRG systems across eleven European countries and has 
three main objectives: 1) to assess classification variables and 
algorithms used to group patients with cholecystectomy into 
DRGs; 2) to compare the composition of these DRGs and 
variations in relative resource intensity; and 3) to determine 
DRGs and hospital price levels for six case vignettes of 
cholecystectomy patients with different combinations of 
demographic, diagnostic and treatment variables.
The results were generated in the framework of the 
EuroDRG project (4), which selected ten episodes of care 
to assess European DRG systems and their ability to define 
homogenous groups of patients. In this article, we focus on 
cholecystectomy as it is one of the most common emergency 
surgical procedures in high-income countries (12–14).
 
Methods
Definition of episode of care and cholecystectomy index case
A common definition for a cholecystectomy EoC was agreed 
as part of the EuroDRG project by researchers from eleven 
European countries (i.e. Austria, England, Estonia, Finland, 
France, Germany, Ireland, the Netherlands, Poland, Spain, 
and Sweden). The definition was based on the International 
Classification of Diseases 10th edition (ICD-10) for diagnoses 
and ICD-9 Clinical Modification (ICD-9CM) for procedures 
and is presented in Box 1. Researchers from each country 
translated the definition into national codes for diagnoses and 
procedures considering available mappings from the Hospital 
Data Project if applicable (15). Similar methods have been 
reported for another episode of care (16–21).
A cholecystectomy index case was defined (i.e. adult age, 
uncomplicated calculus of gallbladder with cholecystitis, 
laparoscopic cholecystectomy, treated as inpatient) to facilitate 
comparisons of relative resource intensity of respective DRGs 
within countries (see Box 1).
Box 1. Definition of EoC and reference case
 Definition
Name                                            → Cholecystectomy
Defined by                                   → Primary procedures AND diagnosis
Primary diagnosis (ICD-10)     → K80.1 (Calculus of gallbladder with other cholecystitis)
Procedure (ICD-9CM)              → 51.2 (Cholecystectomy)
 Index case
Adult age (<36), without complications, non-specific cholecystitis, 
laparoscopic cholecystectomy, treated as inpatient, LOS 4 days
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Data sources
In each country, researchers identified national or 
regional databases of hospital care and obtained access to 
all information necessary for the purposes of this study. 
The number of cholecystectomy cases conforming to our 
definition and the corresponding DRGs were extracted from 
the databases. An overview of the databases and time interval 
(years) of data used for the study in each country are presented 
in Table 1. Databases were required to contain information 
about diagnoses, procedures, and DRGs of individual patients 
in order to make possible identification of cholecystectomy 
patients conform to the agreed definition. The number of 
identified cholecystectomy cases ranged from 1,845 cases in 
Finland to 73,545 cases in Poland (22).
Analysis of Patient Classification Systems (PCSs)
For each country the number of cholecystectomy EoC cases and 
the corresponding DRGs were extracted from the databases. 
Detailed comparative analyses of classification variables and 
of grouping algorithms of national DRG systems (16,23) were 
performed for the most frequent DRGs, i.e. those DRGs that 
individually contained at least 1% of all cholecystectomy 
patients in the relevant database.
Grouping algorithms were mapped graphically to facilitate 
easy comparison of differences and similarities between 
systems (see below). In addition, the percentage of all 
cholecystectomy EoC cases grouped into the DRG and the 
percentage of all cases within each DRG conforming to the 
definition of cholecystectomy was calculated.
Diagnosis-Related Groups (DRGs) and hospital quasi prices
In addition to the index case (see above), six standardised case 
vignettes of patients with different combinations of primary 
and secondary diagnoses, procedures, age and length of stay 
were defined (Table 2). This selection is meant to describe 
the grouping logic of different DRG systems in different 
countries’ systems. Case vignettes one, two and three represent 
more complicated cases of cholelithiasis, while the remaining 
ones are combinations of mixed gravity of primary and 
secondary diagnosis and patient characteristics.
DRG-type hospital payments systems differ between and often 
even within countries, thus, complicating comparisons across 
Table 1. Data years and databases by country
Country Data year Source of data Diagnoses coding Procedure coding
Austria 2008 Procedure-oriented Hospital Financing (LKF) Federal 
Ministry of Health (BMG)
ICD-10-BMSG-2001 Leistungskatalog
England 2007–8 Hospital Episode Statistic (HES) ICD-10 Office of Population Censuses and 
Surveys (OPCS) 
Estonia 2008 Estonian Health Insurance Fund (EHIF) database ICD-10 NOMESCO Classification of Surgical 
Procedures (NCSP)
Finland 2008 Hospital Benchmarking Database ICD-10-FI NCSP-FI
France 2008 Programme of Medicalization of Information Systems: 
medicine, surgery and obstetrics (PMSI MCO)
CIM-10 Classification Commune des Actes 
Médicaux (CCAM)
Germany 2008 Diagnosis Related Groups (DRG-statistik) of the Federal 
Statistical Office (Destatis)
ICD-10-GM OPS Operationen- und 
Prozedurenschlüssel
Ireland 2008 Hospital Inpatient Enquiry (HIPE) database of the Health 
Services Executive (HSE)
ICD-10-AM Australian Classification of Health 
Interventions (ACHI)
Netherlands 2008 Diagnose Behandeling Combinaties (DBC) Onderhoud 
database
ICD-10 Elektronische DBC Typeringslijst
Poland 2009 Register of episodes of care and reimbursements of the 
National Health Fund (NHF)
ICD-10 ICD-9-CM
Sweden 2008 The National Patient Register (NPR) of The Board of 
Health and Welfare
ICD-10-SE KVÅ Klassifikation av vårdåtgärder 
(Swedish adaption of NCSP)
Spain (Catalonia) 2008 Hospital Minimum Basic Data Set (CMBD) database of 
the Public Hospital Network of Catalonia (XHUP)
ICD-9-CM ICD-9-CM
Table 2. Case vignettes: Patient classification variables
Primary diagnosis Secondary diagnoses
Cholecystectomy 
procedure Age Setting
Death during 
admission
LOS 
(days)
Index case K80.1 No Laparoscopic <36 Inpatient No 4
Patient 1 Open with CC K80.0 E11.8, I50.1, I69.3 Open 85 Inpatient Yes 9
Patient 2 Lap with CC K80.1 T81.4 Laparoscopic 49 Inpatient No 16
Patient 3 Lap without CC K80.4 No Laparoscopic 55 Inpatient No 4
Patient 4 Day lap with CC K80.2 E11.9, I11.9 Laparoscopic 69 Day case No 1
Patient 5 Day lap without CC K80.2 No Laparoscopic 25 Day case No 0
Patient 6 Open without CC K80.0 No Open 42 Inpatient No 6
LOS= Length of Stay; CC= Comorbidities or Complications
A list of relevant ICD-10 codes is provided as online material (http://apps.who.int/classifications/icd10/browse/2015/en)
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countries. In order to compare relative resource intensity for 
cholecystectomy as expressed by DRGs in each country, an 
approach similar to that of Koechlin et al. was used (10).
Quasi prices were calculated by converting national DRG 
weights into monetary values using average national 
conversion rates. If necessary, prices were deflated to 2008 
prices using national GDP deflators (24) and converted to 
Euros using average currency exchange rates for the year 2008 
(25). In addition, a quasi-price index was calculated with the 
index case assuming a value of one. The index score of all 
other case vignettes was calculated by dividing the monetary 
value of the quasi price (10) of each case vignette by that of the 
index case.
Results
Figure 1 shows the grouping algorithms and classification 
variables of PCS in the eleven European countries. The 
figure includes classification variables of those DRGs that 
individually represent at least 1% of cholecystectomy cases in 
each country. DRGs containing less than 1% of cases in the 
national database but which are essential for understanding the 
grouping logic are shaded in light grey and are not considered 
in the following analysis. The index DRGs are highlighted in 
dark grey. On the left hand side, the figure specifies for each 
country the version of the DRG system and the percentage 
of all identified cholecystectomy cases that are shown in the 
graph. The last two columns on the right show the percentage 
of cholecystectomy cases covered by each DRG and the DRG 
weight index.
On the left hand side, the figure specifies for each country the 
version of the PCS and the percentage of all cholecystectomy 
cases shown in the graph. The arrows indicate the sequence in 
which different types of classification variables are considered 
in the grouping algorithm. In addition, indicators to assess 
the composition of DRGs and the relative resource intensity 
of cases within each DRG are shown. The Finnish and the 
Swedish algorithms are combined as both use versions of the 
NordDRG system which is very similar for cholecystectomy.
Grouping algorithms classify cholecystectomy cases on 
the basis of different classification variables: 1) type of 
diagnosis, 2) type of procedure, 3) type of admission, 4) the 
level of Comorbidities or Complications (CC), 5) age, and 6) 
length of stay.
Patient classification of cholecystectomy cases in Europe
The figure shows large differences in the DRG systems for the 
11 European countries. For example, in Austria and Poland 
there are two DRGs for a cholecystectomy episode, but in 
England there are nine DRGs. The DRG systems in England, 
France and Estonia use the highest number of variables, 
including a variety of medical conditions and procedures. The 
latter is not directly included in the Frenched system, but there 
is a distinction between patients with acute and non-acute 
conditions.
The type and combination of classification variables also 
vary significantly across countries. The main diagnosis is 
used as a classification variable only in Finland, Sweden, the 
Netherlands and Poland. The Austrian, German and Dutch 
DRG systems do not differentiate patients with CC, while all 
other countries consider CCs in their classification system. 
Yet, most countries only make a distinction between patients 
with and without CCs, while the French GHM (homogeneous 
patient groups) system (26) differentiates between four levels 
of CCs and the German Diagnosis-Related Groups (G-DRG 
system) calculates cumulative Patient Clinical Complexity 
Levels (PCCLs) (27,28).
In all countries, the DRGs are based on cholecystectomy 
procedures (including both open and laparoscopic 
procedures). Open and laparoscopic cholecystectomy 
procedures are included in DRG systems in Estonia, Finland, 
Germany, Ireland, the Netherlands and Sweden. 
Admission is accounted for in Finland, Sweden and in the 
Netherlands. Age serves as a classification variable only in 
France. Length of stay is relevant for grouping cases into 
DRGs only in France, although it is considered either for 
outlier deductions or for additional payments in a number 
of other countries, such as in Austria, England, Germany and 
France (4).
Distribution of cholecystectomy cases and variation in relative 
resource intensity
In most countries, the vast majority of cholecystectomy EoC 
cases are grouped into the shadowed DRG (in Figure 1) 
containing the index case (see Box 1), i.e. between 55% in 
Finland and 92% in Austria. Within these index DRGs, almost 
all patients conform to our EoC definition (i.e. around 
90% or above).
The cost index shows that the index DRG is the lowest 
valued DRG only in Poland, England, Estonia and Spain (see 
Figure 2). Generally, in DRG systems with only three or four 
DRGs for cholecystectomy patients, even the highest valued 
DRG has the cost the index below two. The low variation cost 
index values compared to index case could be an indication 
of differences in coding practices across countries or poor 
quality data. 
The lowest variation in DRG weight index scores exists in 
Austria, Germany, Poland and Netherlands with a range of 
about one. In these countries, but also in England, Finland, 
Sweden and France, indicating that the systems do not 
systematically account for cases that are more than twice as 
resource intensive as the index case. In contrast, the range of 
DRG weight index scores is considerably higher in Ireland 
(0.4-4.0) (see Figure 2).
Diagnosis-Related Groups (DRGs) and hospital quasi prices for 
case vignettes
Table 3 shows a comparison of DRGs and hospital quasi 
prices, reflecting national average hospital payments for each 
case vignette under the assumption that hospital payment 
would be exclusively based on DRGs. For each case vignette, 
the first column specifies the DRG into which a patient would 
be classified and whether he or she would be considered an 
inlier or an outlier, i.e. whether the predefined length of stay 
is above or below the DRG system specific upper or lower 
length of stay threshold. The second column specifies the 
corresponding quasi price for each patient. In the last column 
of the table, the index DRGs (see Figure 1) and corresponding 
quasi prices are presented.
Apparently, large variation in hospital payments exists across 
countries. Index case forms the majority of total cases. Index 
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Figure 1. Graphic illustration of grouping algorithms and classification of PCS in 11 European countries
Major Category Partition ProcedureClassification variables  DRGType of 
Admission
Price / 
weightMain diagnosis
% of cases 
in EoC
Complications/ 
comorbidities
Cholecystectomy
AgeMain 
diagnosis
Netherlands
(DBC 2008)
surgery Regular care
cholecystitis
cholelithiasis
surgical
laparoscopic
inpatient
daycare
inpatient
110003230203 8% 5790
110003230302
110003230303
5%
87%
804
3483
Diseases and 
disorders of  the 
digestive system
556
With Major CC
Without Major CC
Cholecystectomy and other hepatobiliar procedures 3,7%OR 
procedure
11.080,27 €
Spain (Catalonia)
(AP-DRG version 23)
98.9% of cases
Cholecystectomy
Laparoscopic
493With CC 10,1%
494 74,9%Without  CC
5.134,93 €
3.056,64 €
Open
197With CC 2,6%
198 6,2%Without  CC
8.306,62 €
5.113,51 €
Finland
(NordDRG.Fin V2008
97,9% of cases) hepatobiliary 
system and 
pancreas 
diseases
cholecystectomy
open
laparoscopic
inpatient
daycare
without cc
with cc
without cc
with cc
cholecystitis
inpatient
197
198
493
494
494O
Fi:5,26%
Fi:7,26%
Fi:8,70%
Fi:55,53%
Fi:21,10%
11,75
6,37
9,98
7,60
3,89
surgery
Sweden
(NordDRG.Swe
V2008
99% of cases)
with cc
without cc
195
196
Sw:1,97 %
Sw:2,91 %
2,50
1,91
Sw:3,3 % 2,32
Sw:14,12 1,39
Sw:8,74 % 1,46
Sw:59,73 0,98
Sw:8,27 0,61
England
(HRG 4, 2007/8)
Weighted tariffs (£) 
(90.2% of cases are
elective) Hepato-biliary and 
Pancreatic System 
Surgery
Cholecyst-ectomy
GA10A
GA10Bw/o cc
w cc 2643
1529
16.2%
75.7%
FZ12A 39361.8%
General  Abdominal procedures V. Major /Major procedures w intermediate cc
w/o cc
FZ12B
FZ12C
GA07B
GA07A
3226
5194
1.3%
1.0%
GA08A
1.2% 2858
Hepatobiliary Procedures
Category 3
Category 2
w/o cc
w cc
w/o cc
w cc
GA08B
3199<1%
2615<1%
4437<1%
Hepato-biliary
and Pancreatic 
System
Categories  1, 4-8 
[8: most complex / 
costly procedures]
w major cc
Austria
(LKF 2008)
96% of cases
Relevant 
procedure
MEL05.05A 5.644
3.541
Cholecystectomy with  endoscopic diagnostics 4%
92%MEL05.05BCholecystectomy without  endoscopic diagnostics
193 0.88% 2 698 €
194 1.68% 1 521 €
with CC
without CC
with CC
without CC
195
196
0.33%
0.07%
1 871 €
1 792 €
1.94% 2 340 €
3.69% 1 412€
with CC
without CC
197
198
494without CC
with CC 493 13.13%
78.05%
847€
746€
Estonia
(2008)
circulatory 
system diseases surgery
With 
common 
bile duct 
exploration
Other 
biliary tract 
procedures
W/o 
common 
bile duct 
exploration
cholecystectomy 
EXCEPT by laparoscope
Laparoscopic 
cholecystectomy
w/o laparoscopic 
cholecystectomy
cholecystectomy 
EXCEPT by laparoscope
Laparoscopic 
cholecystectomy
Endosc proc of chol or 
pancreas
LOS
Poland
(JGP 2009)
100 % of cases
Procedures of 
gallbladder, 
biliary tract and 
pancreas
Relevant 
procedure
Cholelithiasis
With CC
Cholecystectomy
Without CC
G24
G25
16%
84%
837 €
742 €
Ireland ARDRG v5.1
Based on 2008 data
Hepatobiliary 
sytem and 
pancreas
surgery
Open cholecystectomy with closed CDE
Laparoscopic cholecystectomy without closed CDE
Open cholecystectomy without closed CDE
Laparoscopic cholecystectomy with closed CDE
H07B 5.78% 8,350
H07A 0.92%
with PCCL > 3
18,475
with PCCL ≤ 3
H08B 83.16% 4,645
H08A 8.31% 8,768
with PCCL ≤ 2
with PCCL > 2
Germany
(DRG version 2008)
Diseases and
disorders of the
hepobiliary
system and
pancreas
Laparoscopic
cholecystectomy
Cancer of
hepatobiliary tract
and pancreas or
acute pancreatitis
HiT Type II
H08B
H08A
Laparotomy
Moderately complex
surgical intervention on 
gall bladder and bile duct
H05Z
88%
1,6%
HiT = Heparin induced
Thrombocytopenia
surgery
<1%
No complicating 
diagnosis
2,468
0,896
1,805
Diseases and
disorders of the
hepobiliary
system and
pancreas
OR 
proceure
France
(GHM v11b, 2010)
93% of cases
Cholecystectomy procedures
Acute conditions
No acute conditions
Without CC
with level 4 CC
with level 2 CC
with level 3 CC
Without CC
with level 2 CC
with level 3 CC
with level 4 CC
<3 days
07C131
07C134
07C132
07C133
07C141
07C144
07C142
07C143
22,4%
5,0%
1,9%
<1%
54,7%
6,8%
1,2%
<1%
3402 €
4983 €
8877 €
20109 €
2944€
4379 €
7008 €
12607€
>79
>79 <4 days
<5 days
<3 days>79
>79 <4 days
<5 days>79
>79
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0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
Index case Patient 1: Open with CC Patient 2: Lap with CC
Patient 3: Lap without CC Patient 4: Day lap with CC Patient 5: Day lap without CC
Patient 6: open without CCFigure 2. Comparison of price indices for the cholecystectomy case vignettes in eleven European countries (the price index of the index case 
equals 1.0 in each country)
case is generally a patient with milder condition, without 
comorbidities. However it is observed that only for Estonia, 
England, Poland and Spain the payment for index case is lower 
than for other patient groups. Cases with lower payments 
are mostly found in patient group 5 (day-care laparoscopic 
without CC). Cases in patient group 5 are considerably 
cheaper compared to the index case in Finland, France, 
Germany, Ireland, the Netherlands and Sweden. Similar 
payment compared to the index case is found in Austria, 
England, Estonia, Poland and Spain but this is due to the fact 
that patient group 5 includes the same DRGs as in the index 
case.
DRG price is lower compared to the index case in patient 
group 4 (day-care laparoscopic with CC). The DRG cost of 
this group is lower in almost every country except for England, 
Estonia and Spain. In Finland the DRG price is comparable 
with index case.
The most pricey DRG is in patient group 1 (open with 
CC), which is to be expected because patients in this group 
have undergone open cholecystectomy, with CC and a long 
LOS. Expensive DRGs are also found in patient groups 2 
(laparoscopic with CC) and 3 (laparoscopic without CC), 
although in patient group 3 the DRG cost is similar to the 
index case in Germany and the Netherlands.
The lowest DRG payment level  is in Poland but the most 
expensive in Ireland. For example, the cost of the index 
case is 742 euros in Poland, compared to Ireland where it is 
4,645 euros. Moreover, in patient group 1 this difference is 
considerably higher (837 euros versus 18,475 euros).
Figure 2 shows the ratio of the quasi price of each DRG 
compared to a cholecystectomy without complications 
(index case) per country. The largest variations are found in 
England, Ireland, Spain and Estonia, where patients with open 
cholecystectomy (vignette 1) have a quasi price that is more 
than twice as high as that of the index case. In contrast, only 
slight variations exist in Austria, Poland and the Netherlands. 
In half of the countries, payment for a day case without 
complications (vignette 4 and 5) is below that of the index 
case. Other countries do not have specific DRGs for day cases 
but apply a LOS-based payment reduction for cases staying 
shorter than a lower LOS threshold, and this also applies for 
day cases.
Discussion
This is the most comprehensive available comparative analysis 
of grouping algorithms, classification variables, and prices 
for cholecystectomy patients in different DRG-based hospital 
payment systems in Europe. It shows great variation across 
countries: 1) in the number of DRGs; 2) in the characteristics 
of classification variables; 3) in the degree of differentiation 
between complex and less complex cases; and 4) in the quasi 
prices for different types of patients (case vignettes).
If DRG systems do not adequately account for differences 
among patients, hospitals and surgeons that treat a greater 
share of more complex cases are not adequately compensated 
for their greater efforts. Possibly, in countries with only a 
few DRGs in order to account for differences in complexity, 
some of the variations in patient populations among hospitals 
are accounted for through adjustments (e.g. for teaching 
status or type of hospital) outside of the DRG systems (9). 
However, ideally, differences in patient characteristics would 
be accounted for in the PCS and not in the payment system. 
The implementation of DRGs also raises several other issues. 
In particular, the same clinical situation should be approached 
in an uniform way, but different systems of incentive-based 
funding may induce a potential conflict of interest for a 
doctor. In the worst case, the financial incentives could lead to 
treatments that are clinically inappropriate and to differences 
in DRG coding motivated by those incentives (29).
Moreover, it does not come out from the study what are the 
reasons behind the fact that the same clinical situations are 
priced differently in comparison to the index case. Also, the 
question arises as to what extent the other factors are reflected 
in the DRG cost. In most countries the co-morbidities and 
complications are taken into account in DRGs but their 
influence on DRG cost is most probably not uniform. Thus, 
the question arises as to how much the co-morbidities affect 
the actual prices. 
The DRG system may be observed in several aspects. First, 
their logic is not always the same, even though there is consensus 
about treatment. Technically, DRGs need to be based on both 
economically and clinically meaningful groups. That requires 
careful decisions on the design of the DRG system, such as the 
hierarchy and algorithms used to classify patients into a limited 
number of groups. Economically, patients within one group 
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should have homogeneous costs. Clinically, cases allocated 
to one group should form a distinguishable entity based on 
main diagnosis, severity, co-morbidity and/or treatment 
performed. But what exactly is homogeneous? When are costs 
and/or clinical diagnosis so different that a group should be 
split? (30). Second, DRGs are put together electronically on 
the basis of input data. Since an electronic format is used, there 
is a risk that a lack of data may cause conflicts (administrative 
side, money, information, treatment algorithms, etc.). Thus, 
the question arises whether the DRG system still takes into 
account all the needs. Administrators of a DRG system adjust 
rules for split, fusion or other changes in DRGs. DRGs should 
be put together according to common guidelines, to ensure its 
safety, transparency and, immunity against manipulations.
In drawing meaningful conclusions from this study, it is 
important to be cognisant of its limitations, especially in 
relation to the ability to undertake direct cross-country 
comparisons. First, although there was an agreed definition for 
cholecystectomy, relevant cases in each country were identified 
using a different procedure and (to a lesser extent) diagnosis 
coding schemes. In the absence of a common procedure 
classification system [such as the World Health Organization 
(WHO) has developed for diagnoses], there is a considerable 
cross-country divergence in the schemes implemented. 
Second, coding practice differs across countries. There is 
variation in coding depth: the maximum number of diagnoses 
used in DRG assignment is ten in Finland, but 120 in 
Germany. Furthermore, the propensity to record diagnoses 
and procedures may be related to whether the DRG system is 
used in hospital reimbursement.
Limitations 
Our study has several limitations. Firstly, the data used to 
identify patients and to assess the relative importance of 
different DRGs in different countries, originated from routine 
inpatient databases in eleven countries (see Table 1). Although 
the data can be compared, it must be taken into account the 
fact that countries have different coding practices and the 
quality may not be entirely comparable.
Secondly, countries have different payment systems for 
hospitals, and consequently make the payment levels difficult 
to compare (see Table 3). On the one hand, countries set DRG-
based payment rates at varying levels as they include different 
cost categories. For example, in Germany, fixed capital costs 
are not included in DRG-based payment, whereas in most 
other countries, DRG-based payments are supposed to cover 
capital costs (10). Different systems of additional payments 
exist, e.g. England assigns additional Health Resource Groups 
(HRGs) for certain diagnostic evaluations, such as CT 
scans; Poland and Austria have additional per-diem based 
payments for stays in intensive care units (23). Furthermore, 
in the Dutch and the Finnish DRG systems several DRGs per 
hospital stay can be assigned, each leading to additional DRG-
based payments (4). DRG-based payments are adjusted in 
several countries to account for differences among hospitals 
or regions. Therefore, the absolute price levels should not be 
directly interpreted as reflecting more expensive care in one 
country compared to another. However, relative price levels 
within countries that were used for comparisons in Figure 2 
should be less affected by differences in payment systems as 
they were always compared to the in-country DRG index case.
Thirdly, as we limit part of our comparative analysis to DRGs 
that account for at least 1% of cases (Figure 1), we partially 
neglect how different systems deal with rare outliers, which 
may, however, be particularly relevant for reimbursement 
(31). In addition, there is one more limitation in this study; 
it is possible that some patients were inappropriately coded in 
order to maximize revenues (“up-coding”).
Despite these limitations, our study has major implications 
for surgeons, hospital managers and national authorities 
involved in the redesigning of national DRG systems. First, 
awareness about classification algorithms and variables in other 
countries should encourage surgeons to think about alternative 
and possibly better ways to classify their patients into DRGs. 
For example, three countries (Austria, the Netherlands and 
Germany) do not distinguish between cholecystectomy cases 
with complications. The average length of stay is taken into 
account only in the French DRG system, although it greatly 
affects the price of a cholecystectomy episode. The price index 
of patient groups 4 (day-care laparoscopic with CC) and 5 
(day-care laparoscopic without CC) is lower (<1) for patients 
in France, Germany, Ireland, Netherlands and Sweden (see 
Figure 2). Seven countries (except Austria, England, Poland 
and France) differentiate between open and laparoscopic 
cholecystectomy, which is a very important measure for 
differentiating patients with an episode of cholecystectomy.
Second, DRG systems are meant to provide precise measures 
of the kind of services hospitals deliver. This measure is useful 
only if DRGs describe a sufficiently homogenous group of 
patients (30). Therefore, quantitative research is needed to 
verify whether the most important determinants of cost 
are considered in different PCSs, and whether differences 
among systems reflect country specific differences in 
treatment patterns. However, it is also important for clinicians 
to be aware of the significance of adequately designed 
DRG systems and to engage in optimizing these systems. 
Information presented in this article about how DRG systems 
classify cholecystectomy patients can help surgeons engage 
with national DRG authorities. In the light of increasing 
pressure for cost containment, it is very important that DRG 
systems consider the most important classification variables 
in order to ensure that limited resources are appropriately 
allocated for patients undergoing cholecystectomy.
Conclusion
The present survey shows that the DRG systems can be 
compared, even though there are many limiting factors, 
arising from the particular national characteristics. These 
international comparisons can provide a very useful new 
perspective especially when governments, Ministries of 
Health or payers are investigating how to improve an existing 
DRG system. These researches can also allow countries, which 
are introducing DRG system, to avoid making gross errors or 
mistakes in composing their DRG system.
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